Dr Curiel                Tyler Curiel, M.D., MPH, Laboratory


                           Mission

Dr. Curiel currently treats adult patients with hematologic malignancies, leukemias, lymphomas, multiple myelomas as well as ovarian cancer and Hepatitis C. Dr. Curiel's current research includes trials for ovarian cancer and a prostate cancer vaccine.

Tulane School of Medicine
Department of Medicine
Section of Hematology/Oncology
1430 Tulane Ave., SL-78
New Orleans, Louisiana 70112-2699
Phone: 504-588-5482
FAX: 504-588-5483
email: tcuriel@tulane.edu

                        Lab Members

                                        Shuang Wei, Ph.D
                                        Michael Brumlik, Ph.D.
                                        Mengde Cao, Ph.D.
                                        Ben Daniel, MS

                       Residents and Medical Students

                                        Brian Barnett, M.D.
                                        Charla Poole
                                        Alexander Hillel
                                        Janis Taube
                                        Andy Martin

                            Students

                                        Suzy Thibodeaux



Section of Hematology and Medical Oncology Homepage

Bounce for Life official homepage


RECENT PUBLICATIONS
Full articles with PDF



Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT,
Nature Med., 2003 May;9(5):562-7.

Toxoplasma gondii-Infected Human Myeloid Dendritic Cells Induce T-Lymphocyte Dysfunction and Contact-Dependent Apoptosis
Shuang Wei,1† Florentina Marches,1 Jozef Borvak,1 Weiping Zou,1† Jacqueline Channon, 2 Michael White,3 Jay Radke,3 Marie-France Cesbron-Delauw,4 and Tyler J. Curiel5* Infection and Immunity, Apr. 2002, p. 1750–1760.

Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplama gondii replication
Shuang Wei, Florentina Marches, Ben Daniel, Sabrina Sonda, Kim Heidenreich, Tyler Curiel International Journal for Parisitology, 32 (2002) 969-977.

Targeted adenoviral vectors

Brian G. Barnett a,b, C. Jefferson Crews a, Joanne T. Douglas a,b,* Biochimica et Biophysica Acta, 1575 (2002) 1 – 14.

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
Weiping Zou 1,2, Véronique Machelon3, Aurore Coulomb-L'Hermin4, Jozef Borvak2, Françoise Nome3, Tatyana Isaeva2, Shuang Wei,1,2, Roman Krzysiek5, Ingrid Durand-Gasselin5, Alan Gordon6, Terri Pustilnik7,David T. Curiel7, Pierre Galanaud5, Frédérique Capron4, Dominique Emilie5 &Tyler J. Curiel1 Nature Medicine, volume 7, number 12, December 2001.

Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by b-Chemokines Rather Than IL-12
Weiping Zou,* Jozef Borvak,* Florentina Marches,* Shuang Wei,* Pierre Galanaud,†Dominique Emilie,† and Tyler J. Curiel2*
Journal of Immunology, 2000, 165: 4388-4396.


 Section of Hematology and Medical Oncology Laboratories Homepage


Tulane School of Medicine, Tulane Department of Medicine,
Section of Hematology and Medical Oncology,
Tulane Cancer Center